ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Intravenous Immunoglobulin (IVIg)- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
Published Date: August 2025
|
Report Code: QYRE-Auto-26Q396
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Intravenous Immunoglobulin IVIg Market Insights and Forecast to 2028
BUY CHAPTERS

Intravenous Immunoglobulin (IVIg)- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Code: QYRE-Auto-26Q396
Report
August 2025
Pages:113
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Baxter
Grifols S A
CSL Limited
Octapharma AG
Biotest
Kedrion S p A
Hualan Bio
CNBG
Shanghai Raas
CBPO
LFB Group
BPL
Sichuan Yuanda Shuyang

Intravenous Immunoglobulin (IVIg)- Market Size

The global market for Intravenous Immunoglobulin (IVIg) was estimated to be worth US$ 11550 million in 2024 and is forecast to a readjusted size of US$ 17160 million by 2031 with a CAGR of 5.9% during the forecast period 2025-2031.

Intravenous Immunoglobulin (IVIg)- Market

Intravenous Immunoglobulin (IVIg)- Market

Intravenous Immunoglobulin, also called gamma globulin or antibodies, is a highly purified blood product preparation that is derived from large pools of plasma donors. Plasma from approximately 1,000 to 10,000 persons is present in each unit or “lot” of Intravenous Immunoglobulin.
Global Intravenous Immunoglobulin (IVIg) main players are Baxter, Grifols, CSL, Octapharma, etc. Global top four manufacturers hold a share above 65%. North America is the largest market, with a share about 45%.
This report aims to provide a comprehensive presentation of the global market for Intravenous Immunoglobulin (IVIg), focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Intravenous Immunoglobulin (IVIg) by region & country, by Type, and by Application.
The Intravenous Immunoglobulin (IVIg) market size, estimations, and forecasts are provided in terms of sales volume (K Bottle) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Intravenous Immunoglobulin (IVIg).
Market Segmentation

Scope of Intravenous Immunoglobulin (IVIg)- Market Report

Report Metric Details
Report Name Intravenous Immunoglobulin (IVIg)- Market
Forecasted market size in 2031 US$ 17160 million
CAGR 5.9%
Forecasted years 2025 - 2031
Segment by Type
  • IVIg Liquid
  • IVIg Powder
Segment by Application
  • Immunodeficiency
  • Autoimmune Disease
  • Acute Infection
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Baxter, Grifols, CSL, Octapharma, Biotest, Kedrion, Hualan Bio, CNBG, Shanghai RAAS, CBPO, LFB Group, BPL, Sichuan Yuanda Shuyang
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Intravenous Immunoglobulin (IVIg) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Sales, revenue of Intravenous Immunoglobulin (IVIg) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Sales, revenue of Intravenous Immunoglobulin (IVIg) in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

What is the Intravenous Immunoglobulin (IVIg)- Market size in 2031?

Ans: The Intravenous Immunoglobulin (IVIg)- Market size in 2031 will be US$ 17160 million.

What is the market share of major companies in Intravenous Immunoglobulin (IVIg)- Market?

Ans: Global top four manufacturers hold a share above 65%.

What is the Intravenous Immunoglobulin (IVIg)- Market share by region?

Ans: North America is the largest market, with a share about 45%.

Who are the main players in the Intravenous Immunoglobulin (IVIg)- Market report?

Ans: The main players in the Intravenous Immunoglobulin (IVIg)- Market are Baxter, Grifols, CSL, Octapharma, Biotest, Kedrion, Hualan Bio, CNBG, Shanghai RAAS, CBPO, LFB Group, BPL, Sichuan Yuanda Shuyang

What are the Application segmentation covered in the Intravenous Immunoglobulin (IVIg)- Market report?

Ans: The Applications covered in the Intravenous Immunoglobulin (IVIg)- Market report are Immunodeficiency, Autoimmune Disease, Acute Infection

What are the Type segmentation covered in the Intravenous Immunoglobulin (IVIg)- Market report?

Ans: The Types covered in the Intravenous Immunoglobulin (IVIg)- Market report are IVIg Liquid, IVIg Powder

1 Market Overview
1.1 Intravenous Immunoglobulin (IVIg) Product Introduction
1.2 Global Intravenous Immunoglobulin (IVIg) Market Size Forecast
1.2.1 Global Intravenous Immunoglobulin (IVIg) Sales Value (2020-2031)
1.2.2 Global Intravenous Immunoglobulin (IVIg) Sales Volume (2020-2031)
1.2.3 Global Intravenous Immunoglobulin (IVIg) Sales Price (2020-2031)
1.3 Intravenous Immunoglobulin (IVIg) Market Trends & Drivers
1.3.1 Intravenous Immunoglobulin (IVIg) Industry Trends
1.3.2 Intravenous Immunoglobulin (IVIg) Market Drivers & Opportunity
1.3.3 Intravenous Immunoglobulin (IVIg) Market Challenges
1.3.4 Intravenous Immunoglobulin (IVIg) Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Intravenous Immunoglobulin (IVIg) Players Revenue Ranking (2024)
2.2 Global Intravenous Immunoglobulin (IVIg) Revenue by Company (2020-2025)
2.3 Global Intravenous Immunoglobulin (IVIg) Players Sales Volume Ranking (2024)
2.4 Global Intravenous Immunoglobulin (IVIg) Sales Volume by Company Players (2020-2025)
2.5 Global Intravenous Immunoglobulin (IVIg) Average Price by Company (2020-2025)
2.6 Key Manufacturers Intravenous Immunoglobulin (IVIg) Manufacturing Base and Headquarters
2.7 Key Manufacturers Intravenous Immunoglobulin (IVIg) Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Intravenous Immunoglobulin (IVIg)
2.9 Intravenous Immunoglobulin (IVIg) Market Competitive Analysis
2.9.1 Intravenous Immunoglobulin (IVIg) Market Concentration Rate (2020-2025)
2.9.2 Global 5 and 10 Largest Manufacturers by Intravenous Immunoglobulin (IVIg) Revenue in 2024
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Intravenous Immunoglobulin (IVIg) as of 2024)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 IVIg Liquid
3.1.2 IVIg Powder
3.2 Global Intravenous Immunoglobulin (IVIg) Sales Value by Type
3.2.1 Global Intravenous Immunoglobulin (IVIg) Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global Intravenous Immunoglobulin (IVIg) Sales Value, by Type (2020-2031)
3.2.3 Global Intravenous Immunoglobulin (IVIg) Sales Value, by Type (%) (2020-2031)
3.3 Global Intravenous Immunoglobulin (IVIg) Sales Volume by Type
3.3.1 Global Intravenous Immunoglobulin (IVIg) Sales Volume by Type (2020 VS 2024 VS 2031)
3.3.2 Global Intravenous Immunoglobulin (IVIg) Sales Volume, by Type (2020-2031)
3.3.3 Global Intravenous Immunoglobulin (IVIg) Sales Volume, by Type (%) (2020-2031)
3.4 Global Intravenous Immunoglobulin (IVIg) Average Price by Type (2020-2031)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Immunodeficiency
4.1.2 Autoimmune Disease
4.1.3 Acute Infection
4.2 Global Intravenous Immunoglobulin (IVIg) Sales Value by Application
4.2.1 Global Intravenous Immunoglobulin (IVIg) Sales Value by Application (2020 VS 2024 VS 2031)
4.2.2 Global Intravenous Immunoglobulin (IVIg) Sales Value, by Application (2020-2031)
4.2.3 Global Intravenous Immunoglobulin (IVIg) Sales Value, by Application (%) (2020-2031)
4.3 Global Intravenous Immunoglobulin (IVIg) Sales Volume by Application
4.3.1 Global Intravenous Immunoglobulin (IVIg) Sales Volume by Application (2020 VS 2024 VS 2031)
4.3.2 Global Intravenous Immunoglobulin (IVIg) Sales Volume, by Application (2020-2031)
4.3.3 Global Intravenous Immunoglobulin (IVIg) Sales Volume, by Application (%) (2020-2031)
4.4 Global Intravenous Immunoglobulin (IVIg) Average Price by Application (2020-2031)
5 Segmentation by Region
5.1 Global Intravenous Immunoglobulin (IVIg) Sales Value by Region
5.1.1 Global Intravenous Immunoglobulin (IVIg) Sales Value by Region: 2020 VS 2024 VS 2031
5.1.2 Global Intravenous Immunoglobulin (IVIg) Sales Value by Region (2020-2025)
5.1.3 Global Intravenous Immunoglobulin (IVIg) Sales Value by Region (2026-2031)
5.1.4 Global Intravenous Immunoglobulin (IVIg) Sales Value by Region (%), (2020-2031)
5.2 Global Intravenous Immunoglobulin (IVIg) Sales Volume by Region
5.2.1 Global Intravenous Immunoglobulin (IVIg) Sales Volume by Region: 2020 VS 2024 VS 2031
5.2.2 Global Intravenous Immunoglobulin (IVIg) Sales Volume by Region (2020-2025)
5.2.3 Global Intravenous Immunoglobulin (IVIg) Sales Volume by Region (2026-2031)
5.2.4 Global Intravenous Immunoglobulin (IVIg) Sales Volume by Region (%), (2020-2031)
5.3 Global Intravenous Immunoglobulin (IVIg) Average Price by Region (2020-2031)
5.4 North America
5.4.1 North America Intravenous Immunoglobulin (IVIg) Sales Value, 2020-2031
5.4.2 North America Intravenous Immunoglobulin (IVIg) Sales Value by Country (%), 2024 VS 2031
5.5 Europe
5.5.1 Europe Intravenous Immunoglobulin (IVIg) Sales Value, 2020-2031
5.5.2 Europe Intravenous Immunoglobulin (IVIg) Sales Value by Country (%), 2024 VS 2031
5.6 Asia Pacific
5.6.1 Asia Pacific Intravenous Immunoglobulin (IVIg) Sales Value, 2020-2031
5.6.2 Asia Pacific Intravenous Immunoglobulin (IVIg) Sales Value by Region (%), 2024 VS 2031
5.7 South America
5.7.1 South America Intravenous Immunoglobulin (IVIg) Sales Value, 2020-2031
5.7.2 South America Intravenous Immunoglobulin (IVIg) Sales Value by Country (%), 2024 VS 2031
5.8 Middle East & Africa
5.8.1 Middle East & Africa Intravenous Immunoglobulin (IVIg) Sales Value, 2020-2031
5.8.2 Middle East & Africa Intravenous Immunoglobulin (IVIg) Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Intravenous Immunoglobulin (IVIg) Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions Intravenous Immunoglobulin (IVIg) Sales Value
6.2.1 Key Countries/Regions Intravenous Immunoglobulin (IVIg) Sales Value, 2020-2031
6.2.2 Key Countries/Regions Intravenous Immunoglobulin (IVIg) Sales Volume, 2020-2031
6.3 United States
6.3.1 United States Intravenous Immunoglobulin (IVIg) Sales Value, 2020-2031
6.3.2 United States Intravenous Immunoglobulin (IVIg) Sales Value by Type (%), 2024 VS 2031
6.3.3 United States Intravenous Immunoglobulin (IVIg) Sales Value by Application, 2024 VS 2031
6.4 Europe
6.4.1 Europe Intravenous Immunoglobulin (IVIg) Sales Value, 2020-2031
6.4.2 Europe Intravenous Immunoglobulin (IVIg) Sales Value by Type (%), 2024 VS 2031
6.4.3 Europe Intravenous Immunoglobulin (IVIg) Sales Value by Application, 2024 VS 2031
6.5 China
6.5.1 China Intravenous Immunoglobulin (IVIg) Sales Value, 2020-2031
6.5.2 China Intravenous Immunoglobulin (IVIg) Sales Value by Type (%), 2024 VS 2031
6.5.3 China Intravenous Immunoglobulin (IVIg) Sales Value by Application, 2024 VS 2031
6.6 Japan
6.6.1 Japan Intravenous Immunoglobulin (IVIg) Sales Value, 2020-2031
6.6.2 Japan Intravenous Immunoglobulin (IVIg) Sales Value by Type (%), 2024 VS 2031
6.6.3 Japan Intravenous Immunoglobulin (IVIg) Sales Value by Application, 2024 VS 2031
6.7 South Korea
6.7.1 South Korea Intravenous Immunoglobulin (IVIg) Sales Value, 2020-2031
6.7.2 South Korea Intravenous Immunoglobulin (IVIg) Sales Value by Type (%), 2024 VS 2031
6.7.3 South Korea Intravenous Immunoglobulin (IVIg) Sales Value by Application, 2024 VS 2031
6.8 Southeast Asia
6.8.1 Southeast Asia Intravenous Immunoglobulin (IVIg) Sales Value, 2020-2031
6.8.2 Southeast Asia Intravenous Immunoglobulin (IVIg) Sales Value by Type (%), 2024 VS 2031
6.8.3 Southeast Asia Intravenous Immunoglobulin (IVIg) Sales Value by Application, 2024 VS 2031
6.9 India
6.9.1 India Intravenous Immunoglobulin (IVIg) Sales Value, 2020-2031
6.9.2 India Intravenous Immunoglobulin (IVIg) Sales Value by Type (%), 2024 VS 2031
6.9.3 India Intravenous Immunoglobulin (IVIg) Sales Value by Application, 2024 VS 2031
7 Company Profiles
7.1 Baxter
7.1.1 Baxter Company Information
7.1.2 Baxter Introduction and Business Overview
7.1.3 Baxter Intravenous Immunoglobulin (IVIg) Sales, Revenue, Price and Gross Margin (2020-2025)
7.1.4 Baxter Intravenous Immunoglobulin (IVIg) Product Offerings
7.1.5 Baxter Recent Development
7.2 Grifols
7.2.1 Grifols Company Information
7.2.2 Grifols Introduction and Business Overview
7.2.3 Grifols Intravenous Immunoglobulin (IVIg) Sales, Revenue, Price and Gross Margin (2020-2025)
7.2.4 Grifols Intravenous Immunoglobulin (IVIg) Product Offerings
7.2.5 Grifols Recent Development
7.3 CSL
7.3.1 CSL Company Information
7.3.2 CSL Introduction and Business Overview
7.3.3 CSL Intravenous Immunoglobulin (IVIg) Sales, Revenue, Price and Gross Margin (2020-2025)
7.3.4 CSL Intravenous Immunoglobulin (IVIg) Product Offerings
7.3.5 CSL Recent Development
7.4 Octapharma
7.4.1 Octapharma Company Information
7.4.2 Octapharma Introduction and Business Overview
7.4.3 Octapharma Intravenous Immunoglobulin (IVIg) Sales, Revenue, Price and Gross Margin (2020-2025)
7.4.4 Octapharma Intravenous Immunoglobulin (IVIg) Product Offerings
7.4.5 Octapharma Recent Development
7.5 Biotest
7.5.1 Biotest Company Information
7.5.2 Biotest Introduction and Business Overview
7.5.3 Biotest Intravenous Immunoglobulin (IVIg) Sales, Revenue, Price and Gross Margin (2020-2025)
7.5.4 Biotest Intravenous Immunoglobulin (IVIg) Product Offerings
7.5.5 Biotest Recent Development
7.6 Kedrion
7.6.1 Kedrion Company Information
7.6.2 Kedrion Introduction and Business Overview
7.6.3 Kedrion Intravenous Immunoglobulin (IVIg) Sales, Revenue, Price and Gross Margin (2020-2025)
7.6.4 Kedrion Intravenous Immunoglobulin (IVIg) Product Offerings
7.6.5 Kedrion Recent Development
7.7 Hualan Bio
7.7.1 Hualan Bio Company Information
7.7.2 Hualan Bio Introduction and Business Overview
7.7.3 Hualan Bio Intravenous Immunoglobulin (IVIg) Sales, Revenue, Price and Gross Margin (2020-2025)
7.7.4 Hualan Bio Intravenous Immunoglobulin (IVIg) Product Offerings
7.7.5 Hualan Bio Recent Development
7.8 CNBG
7.8.1 CNBG Company Information
7.8.2 CNBG Introduction and Business Overview
7.8.3 CNBG Intravenous Immunoglobulin (IVIg) Sales, Revenue, Price and Gross Margin (2020-2025)
7.8.4 CNBG Intravenous Immunoglobulin (IVIg) Product Offerings
7.8.5 CNBG Recent Development
7.9 Shanghai RAAS
7.9.1 Shanghai RAAS Company Information
7.9.2 Shanghai RAAS Introduction and Business Overview
7.9.3 Shanghai RAAS Intravenous Immunoglobulin (IVIg) Sales, Revenue, Price and Gross Margin (2020-2025)
7.9.4 Shanghai RAAS Intravenous Immunoglobulin (IVIg) Product Offerings
7.9.5 Shanghai RAAS Recent Development
7.10 CBPO
7.10.1 CBPO Company Information
7.10.2 CBPO Introduction and Business Overview
7.10.3 CBPO Intravenous Immunoglobulin (IVIg) Sales, Revenue, Price and Gross Margin (2020-2025)
7.10.4 CBPO Intravenous Immunoglobulin (IVIg) Product Offerings
7.10.5 CBPO Recent Development
7.11 LFB Group
7.11.1 LFB Group Company Information
7.11.2 LFB Group Introduction and Business Overview
7.11.3 LFB Group Intravenous Immunoglobulin (IVIg) Sales, Revenue, Price and Gross Margin (2020-2025)
7.11.4 LFB Group Intravenous Immunoglobulin (IVIg) Product Offerings
7.11.5 LFB Group Recent Development
7.12 BPL
7.12.1 BPL Company Information
7.12.2 BPL Introduction and Business Overview
7.12.3 BPL Intravenous Immunoglobulin (IVIg) Sales, Revenue, Price and Gross Margin (2020-2025)
7.12.4 BPL Intravenous Immunoglobulin (IVIg) Product Offerings
7.12.5 BPL Recent Development
7.13 Sichuan Yuanda Shuyang
7.13.1 Sichuan Yuanda Shuyang Company Information
7.13.2 Sichuan Yuanda Shuyang Introduction and Business Overview
7.13.3 Sichuan Yuanda Shuyang Intravenous Immunoglobulin (IVIg) Sales, Revenue, Price and Gross Margin (2020-2025)
7.13.4 Sichuan Yuanda Shuyang Intravenous Immunoglobulin (IVIg) Product Offerings
7.13.5 Sichuan Yuanda Shuyang Recent Development
8 Industry Chain Analysis
8.1 Intravenous Immunoglobulin (IVIg) Industrial Chain
8.2 Intravenous Immunoglobulin (IVIg) Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Intravenous Immunoglobulin (IVIg) Sales Model
8.5.2 Sales Channel
8.5.3 Intravenous Immunoglobulin (IVIg) Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
FEATURED COMPANIES
Baxter
Grifols S A
CSL Limited
Octapharma AG
Biotest
Kedrion S p A
Hualan Bio
CNBG
Shanghai Raas
CBPO
LFB Group
BPL
Sichuan Yuanda Shuyang
List of Tables
 Table 1. Intravenous Immunoglobulin (IVIg) Market Trends
 Table 2. Intravenous Immunoglobulin (IVIg) Market Drivers & Opportunity
 Table 3. Intravenous Immunoglobulin (IVIg) Market Challenges
 Table 4. Intravenous Immunoglobulin (IVIg) Market Restraints
 Table 5. Global Intravenous Immunoglobulin (IVIg) Revenue by Company (2020-2025) & (US$ Million)
 Table 6. Global Intravenous Immunoglobulin (IVIg) Revenue Market Share by Company (2020-2025)
 Table 7. Global Intravenous Immunoglobulin (IVIg) Sales Volume by Company (2020-2025) & (K Bottle)
 Table 8. Global Intravenous Immunoglobulin (IVIg) Sales Volume Market Share by Company (2020-2025)
 Table 9. Global Market Intravenous Immunoglobulin (IVIg) Price by Company (2020-2025) & (USD/Bottle)
 Table 10. Key Manufacturers Intravenous Immunoglobulin (IVIg) Manufacturing Base and Headquarters
 Table 11. Key Manufacturers Intravenous Immunoglobulin (IVIg) Product Type
 Table 12. Key Manufacturers Time to Begin Mass Production of Intravenous Immunoglobulin (IVIg)
 Table 13. Global Intravenous Immunoglobulin (IVIg) Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Intravenous Immunoglobulin (IVIg) as of 2024)
 Table 15. Mergers & Acquisitions, Expansion Plans
 Table 16. Global Intravenous Immunoglobulin (IVIg) Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
 Table 17. Global Intravenous Immunoglobulin (IVIg) Sales Value by Type (2020-2025) & (US$ Million)
 Table 18. Global Intravenous Immunoglobulin (IVIg) Sales Value by Type (2026-2031) & (US$ Million)
 Table 19. Global Intravenous Immunoglobulin (IVIg) Sales Market Share in Value by Type (2020-2025)
 Table 20. Global Intravenous Immunoglobulin (IVIg) Sales Market Share in Value by Type (2026-2031)
 Table 21. Global Intravenous Immunoglobulin (IVIg) Sales Volume by Type: 2020 VS 2024 VS 2031 (K Bottle)
 Table 22. Global Intravenous Immunoglobulin (IVIg) Sales Volume by Type (2020-2025) & (K Bottle)
 Table 23. Global Intravenous Immunoglobulin (IVIg) Sales Volume by Type (2026-2031) & (K Bottle)
 Table 24. Global Intravenous Immunoglobulin (IVIg) Sales Market Share in Volume by Type (2020-2025)
 Table 25. Global Intravenous Immunoglobulin (IVIg) Sales Market Share in Volume by Type (2026-2031)
 Table 26. Global Intravenous Immunoglobulin (IVIg) Price by Type (2020-2025) & (USD/Bottle)
 Table 27. Global Intravenous Immunoglobulin (IVIg) Price by Type (2026-2031) & (USD/Bottle)
 Table 28. Global Intravenous Immunoglobulin (IVIg) Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
 Table 29. Global Intravenous Immunoglobulin (IVIg) Sales Value by Application (2020-2025) & (US$ Million)
 Table 30. Global Intravenous Immunoglobulin (IVIg) Sales Value by Application (2026-2031) & (US$ Million)
 Table 31. Global Intravenous Immunoglobulin (IVIg) Sales Market Share in Value by Application (2020-2025)
 Table 32. Global Intravenous Immunoglobulin (IVIg) Sales Market Share in Value by Application (2026-2031)
 Table 33. Global Intravenous Immunoglobulin (IVIg) Sales Volume by Application: 2020 VS 2024 VS 2031 (K Bottle)
 Table 34. Global Intravenous Immunoglobulin (IVIg) Sales Volume by Application (2020-2025) & (K Bottle)
 Table 35. Global Intravenous Immunoglobulin (IVIg) Sales Volume by Application (2026-2031) & (K Bottle)
 Table 36. Global Intravenous Immunoglobulin (IVIg) Sales Market Share in Volume by Application (2020-2025)
 Table 37. Global Intravenous Immunoglobulin (IVIg) Sales Market Share in Volume by Application (2026-2031)
 Table 38. Global Intravenous Immunoglobulin (IVIg) Price by Application (2020-2025) & (USD/Bottle)
 Table 39. Global Intravenous Immunoglobulin (IVIg) Price by Application (2026-2031) & (USD/Bottle)
 Table 40. Global Intravenous Immunoglobulin (IVIg) Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
 Table 41. Global Intravenous Immunoglobulin (IVIg) Sales Value by Region (2020-2025) & (US$ Million)
 Table 42. Global Intravenous Immunoglobulin (IVIg) Sales Value by Region (2026-2031) & (US$ Million)
 Table 43. Global Intravenous Immunoglobulin (IVIg) Sales Value by Region (2020-2025) & (%)
 Table 44. Global Intravenous Immunoglobulin (IVIg) Sales Value by Region (2026-2031) & (%)
 Table 45. Global Intravenous Immunoglobulin (IVIg) Sales Volume by Region (K Bottle): 2020 VS 2024 VS 2031
 Table 46. Global Intravenous Immunoglobulin (IVIg) Sales Volume by Region (2020-2025) & (K Bottle)
 Table 47. Global Intravenous Immunoglobulin (IVIg) Sales Volume by Region (2026-2031) & (K Bottle)
 Table 48. Global Intravenous Immunoglobulin (IVIg) Sales Volume by Region (2020-2025) & (%)
 Table 49. Global Intravenous Immunoglobulin (IVIg) Sales Volume by Region (2026-2031) & (%)
 Table 50. Global Intravenous Immunoglobulin (IVIg) Average Price by Region (2020-2025) & (USD/Bottle)
 Table 51. Global Intravenous Immunoglobulin (IVIg) Average Price by Region (2026-2031) & (USD/Bottle)
 Table 52. Key Countries/Regions Intravenous Immunoglobulin (IVIg) Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
 Table 53. Key Countries/Regions Intravenous Immunoglobulin (IVIg) Sales Value, (2020-2025) & (US$ Million)
 Table 54. Key Countries/Regions Intravenous Immunoglobulin (IVIg) Sales Value, (2026-2031) & (US$ Million)
 Table 55. Key Countries/Regions Intravenous Immunoglobulin (IVIg) Sales Volume, (2020-2025) & (K Bottle)
 Table 56. Key Countries/Regions Intravenous Immunoglobulin (IVIg) Sales Volume, (2026-2031) & (K Bottle)
 Table 57. Baxter Company Information
 Table 58. Baxter Introduction and Business Overview
 Table 59. Baxter Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2020-2025)
 Table 60. Baxter Intravenous Immunoglobulin (IVIg) Product Offerings
 Table 61. Baxter Recent Development
 Table 62. Grifols Company Information
 Table 63. Grifols Introduction and Business Overview
 Table 64. Grifols Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2020-2025)
 Table 65. Grifols Intravenous Immunoglobulin (IVIg) Product Offerings
 Table 66. Grifols Recent Development
 Table 67. CSL Company Information
 Table 68. CSL Introduction and Business Overview
 Table 69. CSL Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2020-2025)
 Table 70. CSL Intravenous Immunoglobulin (IVIg) Product Offerings
 Table 71. CSL Recent Development
 Table 72. Octapharma Company Information
 Table 73. Octapharma Introduction and Business Overview
 Table 74. Octapharma Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2020-2025)
 Table 75. Octapharma Intravenous Immunoglobulin (IVIg) Product Offerings
 Table 76. Octapharma Recent Development
 Table 77. Biotest Company Information
 Table 78. Biotest Introduction and Business Overview
 Table 79. Biotest Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2020-2025)
 Table 80. Biotest Intravenous Immunoglobulin (IVIg) Product Offerings
 Table 81. Biotest Recent Development
 Table 82. Kedrion Company Information
 Table 83. Kedrion Introduction and Business Overview
 Table 84. Kedrion Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2020-2025)
 Table 85. Kedrion Intravenous Immunoglobulin (IVIg) Product Offerings
 Table 86. Kedrion Recent Development
 Table 87. Hualan Bio Company Information
 Table 88. Hualan Bio Introduction and Business Overview
 Table 89. Hualan Bio Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2020-2025)
 Table 90. Hualan Bio Intravenous Immunoglobulin (IVIg) Product Offerings
 Table 91. Hualan Bio Recent Development
 Table 92. CNBG Company Information
 Table 93. CNBG Introduction and Business Overview
 Table 94. CNBG Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2020-2025)
 Table 95. CNBG Intravenous Immunoglobulin (IVIg) Product Offerings
 Table 96. CNBG Recent Development
 Table 97. Shanghai RAAS Company Information
 Table 98. Shanghai RAAS Introduction and Business Overview
 Table 99. Shanghai RAAS Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2020-2025)
 Table 100. Shanghai RAAS Intravenous Immunoglobulin (IVIg) Product Offerings
 Table 101. Shanghai RAAS Recent Development
 Table 102. CBPO Company Information
 Table 103. CBPO Introduction and Business Overview
 Table 104. CBPO Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2020-2025)
 Table 105. CBPO Intravenous Immunoglobulin (IVIg) Product Offerings
 Table 106. CBPO Recent Development
 Table 107. LFB Group Company Information
 Table 108. LFB Group Introduction and Business Overview
 Table 109. LFB Group Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2020-2025)
 Table 110. LFB Group Intravenous Immunoglobulin (IVIg) Product Offerings
 Table 111. LFB Group Recent Development
 Table 112. BPL Company Information
 Table 113. BPL Introduction and Business Overview
 Table 114. BPL Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2020-2025)
 Table 115. BPL Intravenous Immunoglobulin (IVIg) Product Offerings
 Table 116. BPL Recent Development
 Table 117. Sichuan Yuanda Shuyang Company Information
 Table 118. Sichuan Yuanda Shuyang Introduction and Business Overview
 Table 119. Sichuan Yuanda Shuyang Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2020-2025)
 Table 120. Sichuan Yuanda Shuyang Intravenous Immunoglobulin (IVIg) Product Offerings
 Table 121. Sichuan Yuanda Shuyang Recent Development
 Table 122. Key Raw Materials Lists
 Table 123. Raw Materials Key Suppliers Lists
 Table 124. Intravenous Immunoglobulin (IVIg) Downstream Customers
 Table 125. Intravenous Immunoglobulin (IVIg) Distributors List
 Table 126. Research Programs/Design for This Report
 Table 127. Key Data Information from Secondary Sources
 Table 128. Key Data Information from Primary Sources


List of Figures
 Figure 1. Intravenous Immunoglobulin (IVIg) Product Picture
 Figure 2. Global Intravenous Immunoglobulin (IVIg) Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. Global Intravenous Immunoglobulin (IVIg) Sales Value (2020-2031) & (US$ Million)
 Figure 4. Global Intravenous Immunoglobulin (IVIg) Sales Volume (2020-2031) & (K Bottle)
 Figure 5. Global Intravenous Immunoglobulin (IVIg) Sales Price (2020-2031) & (USD/Bottle)
 Figure 6. Intravenous Immunoglobulin (IVIg) Report Years Considered
 Figure 7. Global Intravenous Immunoglobulin (IVIg) Players Revenue Ranking (2024) & (US$ Million)
 Figure 8. Global Intravenous Immunoglobulin (IVIg) Players Sales Volume Ranking (2024) & (K Bottle)
 Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Intravenous Immunoglobulin (IVIg) Revenue in 2024
 Figure 10. Intravenous Immunoglobulin (IVIg) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 11. IVIg Liquid Picture
 Figure 12. IVIg Powder Picture
 Figure 13. Global Intravenous Immunoglobulin (IVIg) Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
 Figure 14. Global Intravenous Immunoglobulin (IVIg) Sales Value Market Share by Type, 2024 & 2031
 Figure 15. Global Intravenous Immunoglobulin (IVIg) Sales Volume by Type (2020 VS 2024 VS 2031) & (K Bottle)
 Figure 16. Global Intravenous Immunoglobulin (IVIg) Sales Volume Market Share by Type, 2024 & 2031
 Figure 17. Global Intravenous Immunoglobulin (IVIg) Price by Type (2020-2031) & (USD/Bottle)
 Figure 18. Product Picture of Immunodeficiency
 Figure 19. Product Picture of Autoimmune Disease
 Figure 20. Product Picture of Acute Infection
 Figure 21. Global Intravenous Immunoglobulin (IVIg) Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
 Figure 22. Global Intravenous Immunoglobulin (IVIg) Sales Value Market Share by Application, 2024 & 2031
 Figure 23. Global Intravenous Immunoglobulin (IVIg) Sales Volume by Application (2020 VS 2024 VS 2031) & (K Bottle)
 Figure 24. Global Intravenous Immunoglobulin (IVIg) Sales Volume Market Share by Application, 2024 & 2031
 Figure 25. Global Intravenous Immunoglobulin (IVIg) Price by Application (2020-2031) & (USD/Bottle)
 Figure 26. North America Intravenous Immunoglobulin (IVIg) Sales Value (2020-2031) & (US$ Million)
 Figure 27. North America Intravenous Immunoglobulin (IVIg) Sales Value by Country (%), 2024 VS 2031
 Figure 28. Europe Intravenous Immunoglobulin (IVIg) Sales Value, (2020-2031) & (US$ Million)
 Figure 29. Europe Intravenous Immunoglobulin (IVIg) Sales Value by Country (%), 2024 VS 2031
 Figure 30. Asia Pacific Intravenous Immunoglobulin (IVIg) Sales Value, (2020-2031) & (US$ Million)
 Figure 31. Asia Pacific Intravenous Immunoglobulin (IVIg) Sales Value by Region (%), 2024 VS 2031
 Figure 32. South America Intravenous Immunoglobulin (IVIg) Sales Value, (2020-2031) & (US$ Million)
 Figure 33. South America Intravenous Immunoglobulin (IVIg) Sales Value by Country (%), 2024 VS 2031
 Figure 34. Middle East & Africa Intravenous Immunoglobulin (IVIg) Sales Value, (2020-2031) & (US$ Million)
 Figure 35. Middle East & Africa Intravenous Immunoglobulin (IVIg) Sales Value by Country (%), 2024 VS 2031
 Figure 36. Key Countries/Regions Intravenous Immunoglobulin (IVIg) Sales Value (%), (2020-2031)
 Figure 37. Key Countries/Regions Intravenous Immunoglobulin (IVIg) Sales Volume (%), (2020-2031)
 Figure 38. United States Intravenous Immunoglobulin (IVIg) Sales Value, (2020-2031) & (US$ Million)
 Figure 39. United States Intravenous Immunoglobulin (IVIg) Sales Value by Type (%), 2024 VS 2031
 Figure 40. United States Intravenous Immunoglobulin (IVIg) Sales Value by Application (%), 2024 VS 2031
 Figure 41. Europe Intravenous Immunoglobulin (IVIg) Sales Value, (2020-2031) & (US$ Million)
 Figure 42. Europe Intravenous Immunoglobulin (IVIg) Sales Value by Type (%), 2024 VS 2031
 Figure 43. Europe Intravenous Immunoglobulin (IVIg) Sales Value by Application (%), 2024 VS 2031
 Figure 44. China Intravenous Immunoglobulin (IVIg) Sales Value, (2020-2031) & (US$ Million)
 Figure 45. China Intravenous Immunoglobulin (IVIg) Sales Value by Type (%), 2024 VS 2031
 Figure 46. China Intravenous Immunoglobulin (IVIg) Sales Value by Application (%), 2024 VS 2031
 Figure 47. Japan Intravenous Immunoglobulin (IVIg) Sales Value, (2020-2031) & (US$ Million)
 Figure 48. Japan Intravenous Immunoglobulin (IVIg) Sales Value by Type (%), 2024 VS 2031
 Figure 49. Japan Intravenous Immunoglobulin (IVIg) Sales Value by Application (%), 2024 VS 2031
 Figure 50. South Korea Intravenous Immunoglobulin (IVIg) Sales Value, (2020-2031) & (US$ Million)
 Figure 51. South Korea Intravenous Immunoglobulin (IVIg) Sales Value by Type (%), 2024 VS 2031
 Figure 52. South Korea Intravenous Immunoglobulin (IVIg) Sales Value by Application (%), 2024 VS 2031
 Figure 53. Southeast Asia Intravenous Immunoglobulin (IVIg) Sales Value, (2020-2031) & (US$ Million)
 Figure 54. Southeast Asia Intravenous Immunoglobulin (IVIg) Sales Value by Type (%), 2024 VS 2031
 Figure 55. Southeast Asia Intravenous Immunoglobulin (IVIg) Sales Value by Application (%), 2024 VS 2031
 Figure 56. India Intravenous Immunoglobulin (IVIg) Sales Value, (2020-2031) & (US$ Million)
 Figure 57. India Intravenous Immunoglobulin (IVIg) Sales Value by Type (%), 2024 VS 2031
 Figure 58. India Intravenous Immunoglobulin (IVIg) Sales Value by Application (%), 2024 VS 2031
 Figure 59. Intravenous Immunoglobulin (IVIg) Industrial Chain
 Figure 60. Intravenous Immunoglobulin (IVIg) Manufacturing Cost Structure
 Figure 61. Channels of Distribution (Direct Sales, and Distribution)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Strategic Venue Partners

SIMILAR REPORTS

Intravenous Antibodies Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Intravenous Injection Immunoglobulin Market Research Report 2024
IVIg Powder Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Lyophilized IVIG Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
IVIg Liquid Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Hyperimmune Globulin Product Market Research Report 2024
Global Human Hyperimmune Globulins Market Research Report 2024
Global Hyperimmune Globulin Injection Market Research Report 2024
Human Plasma derived Hyperimmune Product Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Intravenous Immune Globulin Therapies Market Research Report 2024
Human Plasma based Hyperimmune Preparation Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Hyper Immune Globulin Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Hyperimmune Globulins Market Research Report 2025
Global Human Immunoglobulin pH4 for Intravenous Injection Market Research Report 2024
Immune Globulin Intravenous Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Intravenous Immunoglobulin IVIg Therapy Market Research Report 2025
Human Immune Globulin Intravenous Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Human Immunoglobulin pH4 for Intravenous Injection COVID 19 Market Research Report 2024
Human Normal Immunoglobulin Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Human Immumoglobulin PH4 for Intravenous Injection Market Insights Forecast to 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions